• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Surgical Treatment of Metastatic Bone Disease-When Decisions at End-of-Life Really Makes the Difference.转移性骨病的外科治疗——临终决策何时真正产生影响。
Cancers (Basel). 2021 May 25;13(11):2581. doi: 10.3390/cancers13112581.
2
Communication in surgical decision-making while managing metastatic bone disease: matching patient expectations with surgical goals.在处理转移性骨病时的手术决策沟通：使患者期望与手术目标相匹配。
Support Care Cancer. 2021 Feb;29(2):1111-1119. doi: 10.1007/s00520-020-05595-7. Epub 2020 Jun 30.
3
A prospective longitudinal study investigating outcomes including patient-reported outcome measures after surgery for metastatic bone disease.一项前瞻性纵向研究，调查转移性骨病手术后的结果，包括患者报告的结局指标。
Bone Jt Open. 2021 Feb;2(2):79-85. doi: 10.1302/2633-1462.22.BJO-2020-0173.R1.
4
The prognosis and management of neuroendocrine neoplasms-related metastatic bone disease: lessons from clinical practice.神经内分泌肿瘤相关转移性骨病的预后和管理：来自临床实践的经验教训。
Endocrine. 2019 Jun;64(3):690-701. doi: 10.1007/s12020-019-01838-8. Epub 2019 Jan 11.
5
Functional outcome of operative treatment for pelvic metastatic bone disease from primary thyroid cancer: A case series.原发性甲状腺癌盆腔转移性骨病手术治疗的功能结局：病例系列
Int J Surg Case Rep. 2020;66:288-297. doi: 10.1016/j.ijscr.2019.11.065. Epub 2019 Dec 10.
6
Bone evaluation in paediatric chronic kidney disease: clinical practice points from the European Society for Paediatric Nephrology CKD-MBD and Dialysis working groups and CKD-MBD working group of the ERA-EDTA.儿童慢性肾脏病的骨骼评估：来自欧洲儿科学肾脏病学、CKD-MBD 和透析工作组以及 ERA-EDTA 的 CKD-MBD 工作组的临床实践要点。
Nephrol Dial Transplant. 2021 Feb 20;36(3):413-425. doi: 10.1093/ndt/gfaa210.
7
Economic evaluation of clodronate and zoledronate in patients diagnosed with metastatic bone disease from the perspective of public and third party payors in Brazil.巴西公共和第三方支付者角度下，对于确诊有转移骨病的患者，使用氯膦酸盐和唑来膦酸的经济学评价。
Clin Ther. 2011 Nov;33(11):1769-1780.e2. doi: 10.1016/j.clinthera.2011.09.025. Epub 2011 Oct 22.
8
A scoping review on the surgical management of metastatic bone disease of the extremities.关于四肢转移性骨病手术治疗的范围综述。
BMC Musculoskelet Disord. 2018 Aug 6;19(1):279. doi: 10.1186/s12891-018-2210-8.
9
KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).KDIGO 美国评论：2017 年 KDIGO 慢性肾脏病-矿物质和骨异常（CKD-MBD）诊治临床实践指南更新。
Am J Kidney Dis. 2017 Dec;70(6):737-751. doi: 10.1053/j.ajkd.2017.07.019. Epub 2017 Sep 21.
10
Monoclonal antibodies against RANKL and sclerostin for myeloma-related bone disease: can they change the standard of care?针对 RANKL 和 Sclerostin 的单克隆抗体治疗骨髓瘤相关骨病：它们能改变治疗标准吗？
Expert Rev Hematol. 2019 Aug;12(8):651-663. doi: 10.1080/17474086.2019.1640115. Epub 2019 Jul 16.

本文引用的文献

1
External Validation of PATHFx Version 3.0 in Patients Treated Surgically and Nonsurgically for Symptomatic Skeletal Metastases.手术和非手术治疗有症状性骨转移患者中 PATHFx 版本 3.0 的外部验证。
Clin Orthop Relat Res. 2020 Apr;478(4):808-818. doi: 10.1097/CORR.0000000000001081.
2
Incidence of surgical interventions for metastatic bone disease in the extremities: a population-based cohort study.四肢转移性骨病手术干预的发生率：一项基于人群的队列研究。
Acta Oncol. 2019 Apr;58(4):456-462. doi: 10.1080/0284186X.2018.1549368. Epub 2019 Jan 11.
3
External Validation and Optimization of the SPRING Model for Prediction of Survival After Surgical Treatment of Bone Metastases of the Extremities.四肢骨转移手术治疗后生存预测的 SPRING 模型的外部验证和优化。
Clin Orthop Relat Res. 2018 Aug;476(8):1591-1599. doi: 10.1097/01.blo.0000534678.44152.ee.
4
An Easy-to-Use Prognostic Model for Survival Estimation for Patients with Symptomatic Long Bone Metastases.适用于有症状长骨转移患者生存估计的易于使用的预后模型。
J Bone Joint Surg Am. 2018 Feb 7;100(3):196-204. doi: 10.2106/JBJS.16.01514.
5
A revision of the Tokuhashi revised score improves the prognostic ability in patients with metastatic spinal cord compression.对Tokuhashi修订评分进行的修订提高了转移性脊髓压迫患者的预后预测能力。
J Cancer Res Clin Oncol. 2018 Jan;144(1):33-38. doi: 10.1007/s00432-017-2519-y. Epub 2017 Oct 6.
6
Prognostic role of en-bloc resection and late onset of bone metastasis in patients with bone-seeking carcinomas of the kidney, breast, lung, and prostate: SSG study on 672 operated skeletal metastases.在接受手术治疗的骨骼转移患者中，寻找肾、乳腺、肺和前列腺的骨转移癌的整块切除和骨转移晚期发生的预后作用：672 例骨骼转移 SSG 研究。
J Surg Oncol. 2014 Sep;110(4):360-5. doi: 10.1002/jso.23654. Epub 2014 May 29.
7
Bone metastases from renal cell carcinoma: patient survival after surgical treatment.肾癌骨转移：手术治疗后的患者生存情况。
BMC Musculoskelet Disord. 2010 Jul 3;11:145. doi: 10.1186/1471-2474-11-145.
8
Statistical analysis of arthroplasty register data.关节成形术登记数据的统计分析。
Acta Orthop. 2010 Feb;81(1):10-4. doi: 10.3109/17453671003587168.
9
Prognostic factors and a scoring system for patients with skeletal metastasis.骨转移患者的预后因素及评分系统
J Bone Joint Surg Br. 2005 May;87(5):698-703. doi: 10.1302/0301-620X.87B5.15185.

转移性骨病的外科治疗——临终决策何时真正产生影响。

Surgical Treatment of Metastatic Bone Disease-When Decisions at End-of-Life Really Makes the Difference.

作者信息

Sørensen Michala Skovlund, Petersen Michael Mørk

机构信息

Musculoskeletal Tumor Section, Department of Orthopedics, Rigshospitalet, University Hospital of Copenhagen, Inge Lehmanns Vej 6, DK-2100 Copenhagen Ø, Denmark.

Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark.

出版信息

Cancers (Basel). 2021 May 25;13(11):2581. doi: 10.3390/cancers13112581.

DOI:10.3390/cancers13112581
PMID:34070329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8197483/
Abstract

The current era within the field of surgical treatment of metastatic bone disease (MBD) is best described as the beginning of a paradigm shift [...].

摘要

转移性骨病（MBD）外科治疗领域的当前时代，最好描述为范式转变的开端[...]。